ShareValue scores for PTIX: Valuation 51, Quality 39, Growth 41, Health 52.
PTIXNASDAQ
Protagenic Therapeutics
$0.25
(-3.40%)
PTIXNASDAQ
Protagenic Therapeutics
$0.25(-3.40%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Weak
Growth:Moderate
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
5% to 16%
Rating
Trap Risk
Return
5% to 16%
Valuation
51
Fair Value
Price vs Value
Quality
39
Weak
Business Strength
Growth
41
Moderate
Revenue & Earnings
Health
52
Moderate
Financial Stability
Momentum
8
Bearish
Price Trend
Company Details
About
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.
Market Cap$452,552
P/E RatioN/A
Dividend YieldNone
Sector Rank#2137
Score Analysis
AI Investment Thesis
Data as of:Aug 7, 2026
|Last calculated:Aug 7, 2026